Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02498717 · ClinicalTrials.gov registry record · NA
Preliminary Review of Cold and Active Compression Therapy for Traumatic Calcaneus or Ankle Fractures
A NA study, sponsored by AdventHealth.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT02498717: Completed NA study, sponsored by AdventHealth.
NCT02498717 is a NA study that has completed, run by AdventHealth. The registered enrollment target is 55 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02498717, a NA study, has completed, sponsored by AdventHealth.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
This study will examine the initial efficacy and cost-effectiveness of using the cryocompression therapy model both pre-operatively and post-operatively in patients that have recently suffered a traumatic calcaneus or ankle fracture compared to the standard pre-operative RICE therapy procedures.
Primary Outcome
Reduction in length of stay (LOS) and time of effect (pre-/post-op)
Interventions
- DEVICE GameReady
- OTHER RICE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2015-06-03 |
| Est. Completion | 2017-07-26 |
| Phase | NA |
What the finished NCT02498717 record still lists
NCT02498717 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which GameReady is the first listed.
NCT02498717 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02498717 about?
NCT02498717 is a clinical study titled "Preliminary Review of Cold and Active Compression Therapy for Traumatic Calcaneus or Ankle Fractures". This study will examine the initial efficacy and cost-effectiveness of using the cryocompression therapy model both pre-operatively and post-operatively in patients that have recently suffered a traumatic calcaneus or ankle fracture compared to the standard pre-operative RICE therapy procedures.
What is the current status of trial NCT02498717?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2015-06-03. Estimated completion is 2017-07-26.
What interventions are being tested in trial NCT02498717?
The interventions under investigation include: GameReady (DEVICE), RICE (OTHER).
Who is sponsoring clinical trial NCT02498717?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02498717's enrollment target sits among peer trials
55 1264th of 2000 higher than 733 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI